India’s escalating cancer burden: Accuray helps to bridge the gap with latest configuration of Radixact system

New Delhi: Currently, India sees around 1.4 million new cancer cases annually, and this is expected to increase as timely diagnosis and treatment is limited. It is estimated that 50-60% of patients with cancer will need radiotherapy.

Accuray is stepping up to support these efforts with the introduction of Accuray Helix^TM, a configuration of the Radixact® Treatment Delivery System, a groundbreaking technology built on TomoTherapy® helical platform to help transform cancer treatment in India.

As per the company, Accuray Helix brings flexibility and versatility and is intended to drive improvements in personalization and patient care, while simultaneously facilitating treatment of more patients each day, boosting productivity for clinics and enabling them to efficiently manage the growing demand for cancer care. It allows healthcare providers to address a broad range of cancer types, making it a game changer for clinics in smaller cities.

“At Accuray, our vision is to expand the curative power of radiation therapy to improve as many lives as possible, no matter where they are located,” said Xavier De Misouard, President & General Manager – EIMEA, Accuray. ” Accuray Helix is designed to bridge gaps in care access across countries like India. By providing advanced, fast, and precise treatments, we are enabling medical teams to reach more patients and help improve outcomes nationwide.”

Vidhi Prasad, Managing Director – India & Subcontinent, Accuray, emphasized the importance of collaboration in this mission. “We are actively working with healthcare providers all across India to deliver precision technology for cancer care. We strive to empower healthcare professionals to manage increased patient loads without compromising the quality of care, helping to ensure that no patient is left behind,” he said.

For customers seeking radiotherapy solutions with fast throughput, advanced technologies like Accuray Helix play a crucial role in expanding access to timely and efficient cancer treatments. Increased public awareness, enhanced early detection programs, and continued training for healthcare professionals in rural areas are key to improving patient outcomes. Moreover, collaborative efforts between the government, private sector, and non-governmental organizations will be crucial to reducing cancer incidence and ensuring timely access to cutting-edge treatments.